Quintiles is the world's largest provider of biopharmaceutical development and commercial outsourcing services, with over 27,000 employees conducting business in more than 100 countries. Quintiles has helped develop or commercialize 100% of the top 50 best selling products or compounds from 2012. Quintiles provides integrated healthcare services across a product's entire lifecycle, from preclinical development to commercialization.

1. 1
Quintiles Overview
Quintiles applies the breadth and depth of our service offerings along with
extensive therapeutic, scientific and analytics expertise to help our customers
navigate an increasingly complex healthcare environment as they seek to improve
efficiency and effectiveness in the delivery of better healthcare outcomes.
• Quintiles is the world’s largest provider of
biopharmaceutical development and
commercial outsourcing services with a
network of more than 27,000 employees
conducting business in more than 100
countries.
• Quintiles has helped develop or commercialize
100% of 2012’s top 50 best selling products or
compounds
A fully integrated life cycle healthcare services provider
Evaluate Pharma 2011 Report Top Selling Products, May 2, 2012; Quintiles internal project management databases.

2. 2
NDA Regulatory
Review
Biopharmaceutical Services
Companies
Payer and Provider
Commercial
Drug
Approval
Product Development Services Integrated Healthcare Services
Biopharma Development Customers
Biopharma Commercial &
Other Customers
Preclinical
customers
IND Regulatory
Review

3. 3
Programmatic Differentiation and
Outsourcing
All activities of bio-
pharma company
Core capabilities that
differentiate the
company
Activities that the
company can
efficiently develop
internally
Core capabilities that
cannot be develop
efficiently internally
Capabilities that do
not differentiate the
company
Programmatic approach to
differentiation

4. 4
Examples of Programmatic
Differentiation
• Expertise in disease
• Understanding of
mechanism of action of
drug
• Novel study-design
Differentiated- internally
developed
• Database of electronic
medical records for
planning and design
capabilities (Infosario
Design)
• Biomarker development,
industrialization and global
dissemination (ADL)
• Market-access
commercial-clinical
convergence
Core but unable to
develop efficiently
• Global regulatory
submission capability
• Clinical operations
activities (site initiation,
monitoring, drug
accountability)
• Data management
• PV reporting
Non-core

5. 5
Factors to Consider When Selecting
a Service-provider
• Bio-tech corporate strategy
> Anticipated duration of collaboration
> Exit strategy
• Bio-tech/service provider alignment
> Therapeutic area alignment
> Size-alignment
> Country, regional and global alignment
• Benchmarking- trust but verify
• The service provider
> Financial stability
> Ethics and governance